272
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Antibiofilm Activity of Essential Fatty Acids Against Candida albicans from Vulvovaginal Candidiasis and Bloodstream Infections

, , , , , , ORCID Icon & show all
Pages 4181-4193 | Published online: 03 Aug 2022

Figures & data

Figure 1 Chemical structure of EFAs. (A) ALA, α-linolenic acid. (B) EPA, eicosapentaenoic acid. (C) DHA, docosahexaenoic acid. (D) LOA, linoleic acid. (E) GLA, γ-linolenic acid. (F) AA, arachidonic acid.

Figure 1 Chemical structure of EFAs. (A) ALA, α-linolenic acid. (B) EPA, eicosapentaenoic acid. (C) DHA, docosahexaenoic acid. (D) LOA, linoleic acid. (E) GLA, γ-linolenic acid. (F) AA, arachidonic acid.

Figure 2 The biofilm formation ability of C. albicans strains from vulvovaginal candidiasis (VVC) and candidemia.

Figure 2 The biofilm formation ability of C. albicans strains from vulvovaginal candidiasis (VVC) and candidemia.

Figure 3 Distribution of the minimum inhibitory concentrations (MICs) of fluconazole among C. albicans strains from vulvovaginal candidiasis (VVC) and candidemia.

Figure 3 Distribution of the minimum inhibitory concentrations (MICs) of fluconazole among C. albicans strains from vulvovaginal candidiasis (VVC) and candidemia.

Table 1 The MICs, MBICs, and MBECs of Fluconazole Against C. albicans Strains

Figure 4 Inhibitory effect of essential fatty acids (EFAs) on biofilm formation of C. albicans. (A) 0.01 mM EFAs. (B) 0.1 mM EFAs. (C) 1 mM EFAs. The values shown are means ± standard deviations. An asterisk denotes a statistically significant difference compared to the untreated control (P < 0.05).

Figure 4 Inhibitory effect of essential fatty acids (EFAs) on biofilm formation of C. albicans. (A) 0.01 mM EFAs. (B) 0.1 mM EFAs. (C) 1 mM EFAs. The values shown are means ± standard deviations. An asterisk denotes a statistically significant difference compared to the untreated control (P < 0.05).

Figure 5 Eradication effect of essential fatty acids (EFAs) on mature biofilm of C. albicans. (A) 0.01 mM EFAs. (B) 0.1 mM EFAs. (C) 1 mM EFAs. The values shown are means ± standard deviations. An asterisk denotes a statistically significant difference compared to the untreated control (P < 0.05).

Figure 5 Eradication effect of essential fatty acids (EFAs) on mature biofilm of C. albicans. (A) 0.01 mM EFAs. (B) 0.1 mM EFAs. (C) 1 mM EFAs. The values shown are means ± standard deviations. An asterisk denotes a statistically significant difference compared to the untreated control (P < 0.05).

Table 2 The MICs of Fluconazole in Combination with EFAs Against C. albicans Strains

Table 3 The MBICs of Fluconazole in Combination with EFAs Against C. albicans Strains

Table 4 The MBECs of Fluconazole in Combination with EFAs Against C. albicans Strains

Figure 6 Growth curves of C. albicans strains in the absence (control) or the presence of different concentrations of essential fatty acids (EFAs). (AC) C. albicans Y26, (DF) C. albicans Y38, (GI) C. albicans Y65, and (JL) C. albicans X52. The McF values were determined every hour during 14 h.

Figure 6 Growth curves of C. albicans strains in the absence (control) or the presence of different concentrations of essential fatty acids (EFAs). (A–C) C. albicans Y26, (D–F) C. albicans Y38, (G–I) C. albicans Y65, and (J–L) C. albicans X52. The McF values were determined every hour during 14 h.